AlzeCure Pharma AB (publ) (STO:ALZCUR)

AlzeCure Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	271	102	193	257	225	342
Market Cap Growth	205.62%	-47.41%	-24.88%	14.39%	-34.33%	120.98%
Enterprise Value	215	62	156	220	162	209
Last Close Price	2.36	1.09	2.79	3.71	5.12	7.80
PB Ratio	5.35	3.88	8.12	4.25	6.82	3.09
P/TBV Ratio	5.35	3.88	8.13	4.25	6.82	3.09
P/FCF Ratio	-	-	63.16	-	-	-
P/OCF Ratio	-	-	63.16	-	-	-
EV/FCF Ratio	-6.24	-	50.91	-	-	-
Quick Ratio	4.68	4.03	3.72	2.60	3.42	16.23
Current Ratio	4.75	4.15	3.84	2.66	3.49	16.38
Return on Equity (ROE)	-90.86%	-141.05%	-88.22%	-120.35%	-108.23%	-48.75%
Return on Assets (ROA)	-45.54%	-68.06%	-46.61%	-60.70%	-59.75%	-29.56%
Return on Capital (ROIC)	-55.84%	-90.51%	-56.89%	-75.66%	-67.96%	-30.75%
Return on Capital Employed (ROCE)	-74.30%	-138.20%	-161.30%	-93.50%	-237.00%	-65.00%
Earnings Yield	-14.44%	-34.70%	-19.25%	-21.88%	-34.62%	-20.86%
FCF Yield	-12.70%	-34.71%	1.58%	-38.87%	-31.46%	-20.51%
Buyback Yield / Dilution	-32.92%	-24.26%	-30.17%	-26.30%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.